Array BioPharma, Inc. (ARRY) and Genentech (RHHBY)'s Strategic Alliance Voted Breakthrough Alliance of 2012
5/15/2012 10:07:41 AM
BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) announced today that the strategic alliance between Array and Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has been honored with the Breakthrough Alliance Award of 2012. The award, sponsored by Deloitte Recap, was presented at the Allicense 2012 Conference in San Francisco. Annually, the Allicense Conference nominates five biotech-pharmaceutical alliances as the breakthrough deals of the previous year. The award is bestowed upon the alliance that receives the most votes by biotech and pharmaceutical business development and licensing executives.